Phase 4 Metabolic risk Clinical Trials
3 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–3 of 3 trials
Recruiting
Phase 4
Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults
ObesityCardiometabolic Risk FactorsWeight Reduction
Asian Institute Of Medical Sciences60 enrolled1 locationNCT07513168
Recruiting
Phase 4
DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis
Cardiometabolic Risk FactorsCirrhosisCirrhotic Cardiomyopathy+1 more
Post Graduate Institute of Medical Education and Research, Chandigarh400 enrolled1 locationNCT07322237
Recruiting
Phase 4
Study investigating whether the drug semaglutide could be a safe and effective way of reducing metabolic problems, such as a high Body Mass Index (BMI) and high blood sugar levels, in people with psychosis.
Metabolic riskPsychosis
South Eastern Sydney Local Health District100 enrolled1 locationACTRN12621001434886